A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk. A new study indicates that the ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Are you somebody who is focused on trying to lose weight, but for some reason can’t? There could be several reasons for ...

Genevieve Roberts thought weight-loss drugs were a miracle – until excruciating side-effects sent her straight back to a ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

For patients looking for a sustainable weight-loss treatment, the service's clinicians can prescribe a Mounjaro KwikPen, a new once-weekly injectable medication ... that by week 72 people can ...